HCC	Hepatocellular Carcinoma	ICC	Intrahepatic Cholangiocarcinoma
ECC	Extrahepatic Cholangiocarcinoma	SBRT	Stereotactic Body Radiotherapy
TKI	Tyrosine Kinase Inhibitor	PTM	Post-translational Modification
VAN	Vandetanib	PARP	Poly ADP Ribose Polymerase
DNA	Deoxyribonucleic Acid	VEGF(R)	Vascular Endothelial Growth Factor (Receptor)
EGF(R)	Epidermal Growth Factor (Recptor)	RET	REarranged during Transfection Receptor
mTOR	Mammalian Target of Rapamycin	GAPDH	Glyceraldehyde 3-phosphate dehydrogenase
2D	Two Dimensional	3D	Three Dimensional
RER	Radiation Enhancement Ratio	IC${}_{50}$	Inhibitory Concentration at 50% Maxima
p	probability value	CI	Confidence Interval
IQR	Interquartile Range	CDI	Coefficient of Drug Interaction
ANOVA	ANalysis of VAriance	MDPI	Multidisciplinary Digital Publishing Institute
SI units were used unless otherwise stated.